MODELING THE CHEMOPROTECTIVE FUNCTIONS OF GLUTATHIONE S-TRANSFERASES IN CULTURED CELL LINES BY HETEROLOGOUS EXPRESSION*

REFERENCES

• Weinstein I. B. The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment—Twenty-seventh G.H.A. Clowes memorial lecture. Cancer Res. 1988; 48: 4135–4143
   PubMed Web of Science ®Google Scholar
• Tlsty T. D., Briot A., Gualberto A., Hall I., Hess S., Hixon M., Kuppuswamy D., Romanov S., Sage M., White A. Genomic instability and cancer (Review). Mutat. Res. 1995; 337: 1–7
   PubMed Web of Science ®Google Scholar
• Loeb L. A. Mutator phenotype may be required for multistage carcinogenesis (Review). Cancer Res. 1991; 51: 3075–3079
   PubMed Web of Science ®Google Scholar
• Powis G., Alberts D. S. Inhibiting intracellular signalling as a strategy for cancer chemoprevention. Eur. J. Cancer 1994; 30a(8)1138–1144
   PubMed Web of Science ®Google Scholar
• Berenblum I. Cancer prevention as a realizable goal. Cancer 1981; 47: 2346–2348
   PubMed Web of Science ®Google Scholar
• Ames B. N., Magaw R., Gold L. S. Ranking possible carcinogenic hazards. Science 1987; 236: 271–280
   PubMed Web of Science ®Google Scholar
• Ames B. N., Profet M., Gold L. S. Nature's chemicals and synthetic chemicals: Comparative toxicology. Proc. Natl. Acad. Sci. USA 1990; 87: 7782–7786
   PubMed Web of Science ®Google Scholar
• Higginson J. Changing concepts in cancer prevention: Limitations and implications for future research in environmental carcinogenesis (Review). Cancer Res. 1988; 48: 1381–1389
   PubMed Web of Science ®Google Scholar
• Slaga T. J. Inhibition of the induction of cancer by antioxidants. Adv. Exp. Med. Biol. 1995; 369: 167–174
   PubMedGoogle Scholar
• O'Brien P. J. Antioxidants and cancer: Molecular mechanisms. Adv. Exp. Med. Biol. 1994; 366: 215–239
   PubMedGoogle Scholar
• Cerutti P., Ghosh R., Oya Y., Amstad P. The role of the cellular antioxidant defense in oxidant carcinogenesis (Review). Environ. Heatlh Perspect. 1994; 10: 123–129
   Google Scholar
• Feig D. I., Reid T. M., Loeb L. A. Reactive oxygen species in tumorigenesis (Review). Cancer Res. 1994; 54: 1890s–1894s
   PubMed Web of Science ®Google Scholar
• Jakoby W. B. The Enzymatic Basis of Detoxification. Academic Press, New York 1980
   Google Scholar
• Vickers P. J., Townsend A. J., Cowan K. H. Mechanisms of Resistance to Antineoplastic Drugs. CRC Press, Boca Raton, FL 1988; 2: 117–152
   Google Scholar
• Wolf C. R. Metabolic factors in cancer susceptibility (Review). Cancer Surveys 1990; 9: 437–474
   PubMedGoogle Scholar
• Meister A., Anderson M. Glutathione. Ann. Rev. Biochem. 1983; 52: 711–760
   PubMed Web of Science ®Google Scholar
• Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 1994; 54: 1969s–1975s
   PubMed Web of Science ®Google Scholar
• Langouet S., Coles B., Morel F., Becquemont L., Beaune P., Guengerich F. P., Ketterer B., Guillouzo A. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res. 1995; 55: 5574–5579
   PubMed Web of Science ®Google Scholar
• Helzlsouer K. J., Kensler T. W. Cancer chemoprotection by oltipraz: Experimental and clinical considerations (Review). Prevent. Med. 1993; 22: 783–795
   PubMed Web of Science ®Google Scholar
• Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis (Review). Mutat. Res. 1988; 202: 343–361
   PubMed Web of Science ®Google Scholar
• Paolini M., Mesirca R., Gialluca N., Bauer C., Biagi G. L., Cantelli F. G. On cancer chemoprevention: Complications and limitations of some proposed strategies. Carcinogenesis 1995; 16: 971–972
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W. What are the critical attributes for cancer chemopreventive agents? (Review). Ann. NY Acad. Sci. 1995; 768: 73–81
   PubMed Web of Science ®Google Scholar
• Kelloff G. J., Boone C. W., Steele V. E., Fay J. R., Lubet R. A., Crowell J. A., Sigman C. C. Mechanistic considerations in chemopreventive drug development. J. Cell Biochem. 1994; 20: 1–24
   Google Scholar
• Boone C. W., Wattenberg L. W. Current strategies of cancer chemoprevention: 13th Sapporo Cancer Seminar. Cancer Res. 1994; 54: 3315–3318
   PubMed Web of Science ®Google Scholar
• Kensler T., Styczynski P., Groopman J., Helzlsouer K., Curphey T., Maxuitenko Y., Roebuck B. D. Mechanisms of chemoprotection by oltipraz. J. Cell Biochem. 1992, Suppl.: 167–172
   Google Scholar
• Egner P. A., Kensler T. W., Prestera T., Talalay P., Libby A. H., Joyner H. H., Curphey T. J. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 1994; 15: 177–181
   PubMed Web of Science ®Google Scholar
• Clapper M. L., Everley L. C., Strobel L. A., Townsend A. J., Engstrom P. F. Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz. Molec. Pharmacol. 1994; 45: 469–474
   PubMed Web of Science ®Google Scholar
• Anderson L., Steele V. K., Kelloff G. J., Sharma S. Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver (Review). J. Cell. Biochem. 1995; 22(Suppl.): 108–116
   Google Scholar
• Stohs S. J., Lawson T. A., Anderson L., Bueding E. Effects of oltipraz, BHA, ADT and cabbage on glutathione metabolism, DNA damage and lipid peroxidation in old mice. Mech. Ageing Devel. 1986; 37: 137–145
   PubMed Web of Science ®Google Scholar
• Primiano T., Egner P. A., Sutter T. R., Kelloff G. J., Roebuck B. D., Kensler T. W. Intermittent dosing with oltipraz: Relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res. 1995; 55: 4319–4324
   PubMed Web of Science ®Google Scholar
• Williams G. M., Iatropoulos M. J. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Lett. 1996; 104: 49–53
   PubMed Web of Science ®Google Scholar
• Kensler T. W., Egner P. A., Davidson N. E., Roebuck B. D., Pikul A., Groopman J. D. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases. Cancer Res. 1986; 46: 3924–3931
   PubMed Web of Science ®Google Scholar
• Sparnins V. L., Barany G., Wattenberg L. W. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 1988; 9: 131–134
   PubMed Web of Science ®Google Scholar
• Monks T. J., Anders M. W., Dekant W., Stevens J. L., Lau S. S., van Bladeren P. J. Glutathione conjugate mediated toxicities. Toxicol. Appl. Pharmacol. 1990; 106: 1–19
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Metabolism and genotoxicity of dihaloalkanes (Review). Adv. Pharmacol. 1994; 27: 211–236
   PubMedGoogle Scholar
• Simula T. P., Glancey M. J., Wolf C. R. Human glutathione S-transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: Studies with halogenated compounds, aromatic amines and aflatoxin B1. Carcinogenesis 1993; 14: 1371–1376
   PubMed Web of Science ®Google Scholar
• Nebert D., Petersen D., Fornace J. A. Cellular responses to oxidative stress: The [AH] gene battery as a paradigm. Environ. Health Perspect. 1990; 88: 13–25
   PubMed Web of Science ®Google Scholar
• Daniel V. Glutathione S-transferases: Gene structure and regulation of expression. Crit. Rev. Biochem. Molec. Biol. 1993; 28: 173–207
   PubMed Web of Science ®Google Scholar
• Buetler T. M., Gallagher E. P., Wang C., Stahl D. L., Hayes J. D., Eaton D. L. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol. Appl. Pharmacol. 1995; 135: 45–57
   PubMed Web of Science ®Google Scholar
• Pinkus R., Weiner L. M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J. Biol. Chem. 1996; 271: 13422–13429
   PubMed Web of Science ®Google Scholar
• Pulford D. J., Hayes J. D. Characterization of the rat glutathione S-transferase Yc2 subunit gene, GSTA5: Identification of a putative antioxidant-responsive element in the 5′-flanking region of rat GSTA5 that may mediate chemoprotection against aflatoxin B1. Biochem. J. 1996; 318: 75–84
   PubMed Web of Science ®Google Scholar
• Liu S. X., Pickett C. B. The rat liver glutathione S-transferase Ya subunit gene: Characterization of the binding properties of a nuclear protein from HepG2 cells that has high affinity for the antioxidant response element. Biochemistry 1996; 35: 11517–11521
   PubMed Web of Science ®Google Scholar
• Mannervik B. Evolution of glutathione transferases and related enzymes for the protection of cells against electrophiles. Biochem. Soc. Trans. 1996; 24: 878–880
   PubMed Web of Science ®Google Scholar
• Mannervik B., Danielson U. H. Glutathione transferases—structure and catalytic activity (Review). Crit. Rev. Biochem. 1988; 23: 283–337
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Pulford D. J. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Molec. Biol. 1995; 30: 445–600
   PubMed Web of Science ®Google Scholar
• Ketterer B., Meyer D. J., Taylor J. B., Pemble S., Coles B., Fraser G. GSTs and protection against oxidative stress. Glutatione S-Transferases and Drug Resistance, J. D. Hayes, C. B. Pickett, T. J. Mantle. Taylor and Francis, London 1990; 97–110
   Google Scholar
• Commandeur J. N., Stijntjes G. J., Vermeulen N. P. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics (Review). Pharmacol. Rev. 1995; 47: 271–330
   PubMed Web of Science ®Google Scholar
• Pickett C. Glutathione S-transferases: Gene structure, regulation, and biological function. Annu. Rev. Biochem. 1989; 58: 743–764
   PubMed Web of Science ®Google Scholar
• Moody D. E., Narloch B. A., Shull L. R., Hammock B. D. The effect of structurally divergent herbicides on mouse liver xenobiotic-metabolizing enzymes (P-450-dependent mono-oxygenases, epoxide hydrolases and glutathione S-transferases) and carnitine acetyltransferase. Toxicol. Lett. 1991; 59: 175–185
   PubMed Web of Science ®Google Scholar
• Townsend A. J., Cowan K. H. Glutathione S-transferases and drug resistance (Review). Cancer Bull. 1989; 41: 31–37
   Google Scholar
• Morrow C. S., Cowan K. H. Glutathione S-transferases and drug resistance. Cancer Cells 1990; 2: 15–17
   PubMed Web of Science ®Google Scholar
• Black S. M., Wolf C. R. The role of glutathione-dependent enzymes in drug resistance (Review). Pharmacol. Therapeut. 1991; 51: 139–154
   PubMed Web of Science ®Google Scholar
• Puchalski R. B., Fahl W. E. Expression of recombinant glutathione S-transferase pi, Ya, or Yb1 confers resistance to alkylating agents. Proc. Natl. Acad. Sci. USA 1990; 87: 2443–2447
   PubMed Web of Science ®Google Scholar
• Manoharan T. H., Welch P. J., Gulick A. M., Puchalski R. B., Lathrop A. L., Fahl W. E. Expression of tandem glutathione S-transferase recombinant genes in COS cells for analysis of efficiency of protein expression and associated drug resistance. Molec. Pharmacol. 1991; 39: 461–467
   PubMed Web of Science ®Google Scholar
• Miyazaki M., Kohno K., Saburi Y., Matsuo K., Ono M., Kuwano M., Tsuchida S., Sato K., Sakai M., Muramatsu M. Drug resistance to cis-diamminedichloroplatinum(II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase Pi gene. Biochem. Biophys. Res. Commun. 1990; 166: 1358–1364
   PubMed Web of Science ®Google Scholar
• Nakagawa K., Saijo N., Tsuchida S., Sakai M., Tsunokawa Y., Yokota J., Muramatsu M., Sato K., Terada M., Tew K. D. Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem. 1990; 265: 4296–4301
   PubMed Web of Science ®Google Scholar
• Townsend A. J., Goldsmith M. E., Pickett C. B., Cowan K. H. Isolation, characterization, and expression in Escherichia coli of two murine mu class glutathione S-transferase cDNAs homologous to the rat subunits 3 (Yb1) and 4 (Yb2). J. Biol. Chem. 1989; 264: 21582–21590
   PubMed Web of Science ®Google Scholar
• Leyland-Jones B., Townsend A. J., Tu C. P., Cowan K. H., Goldsmith M. E. Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene. Cancer Res. 1991; 51: 587–594
   PubMed Web of Science ®Google Scholar
• Moscow J. A., Townsend A. J., Cowan K. H. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GSTπ gene and its effect on sensitivity to toxins. Molec. Pharmacol. 1989; 36: 22–28
   PubMed Web of Science ®Google Scholar
• Leier I., Jedlitschky G., Buchholz U., Cole S., Deeley R. G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 1994; 269: 27807–27810
   PubMed Web of Science ®Google Scholar
• Müller M., Meijer C., Zaman G., Borst P., Scheper R. J., Mulder N. H., De Vries E., Jansen P. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 1994; 91: 13033–13037
   PubMed Web of Science ®Google Scholar
• Keppler D., Leier I., Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2 (Review). Biol. Chem. 1997; 378: 787–791
   PubMed Web of Science ®Google Scholar
• Paul S., Breuninger L. M., Tew K. D., Shen H. X., Kruh G. D. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. Proc. Natl. Acad. Sci. USA 1996; 93: 6929–6934
   PubMed Web of Science ®Google Scholar
• Grant C. E., Valdimarsson G., Hipfner D. R., Almquist K. C., Cole S., Deeley R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 1994; 54: 357–361
   PubMed Web of Science ®Google Scholar
• Shen H. X., Paul S., Breuninger L. M., Ciaccio P. J., Laing N. M., Helt M., Tew K. D., Kruh G. D. Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry 1996; 35: 5719–5725
   PubMed Web of Science ®Google Scholar
• Müller M., De V. E., Jansen P. Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells. J. Hepatol. 1996; 1: 100–108
   Google Scholar
• Pulaski L., Jedlitschky G., Leier I., Buchholz U., Keppler D. Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur. J. Biochem. 1996; 241: 644–648
   PubMedGoogle Scholar
• Morrow C. S., Diah S., Smitherman P. K., Schneider E., Townsend A. J. Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis 1998; 19: 109–115
   PubMed Web of Science ®Google Scholar
• Fields W. R., Li Y., Townsend A. J. Protection by transfected glutathione S-transferase isozymes against carcinogen-induced alkylation of cellular macromolecules in human MCF-7 cells. Carcinogenesis 1994; 15: 1155–1160
   PubMed Web of Science ®Google Scholar
• Morrow C. S., Smitherman P. K., Diah S. K., Schneider E., Townsend A. J. Coordinated action of glutathione S-transferases (GST) and multidrug resistance protein (MRP) in antineoplastic drug detoxification: Mechanism of GSTA1-1- and MRP-associated resistance to chlorambucil in MCF-7 breast carcinoma cells. J. Biol. Chem. 1998; 273: 20114–20120
   PubMed Web of Science ®Google Scholar
• Simula A. P., Crichton M. B., Black S. M., Pemble S., Bligh H. F., Beggs J. D., Wolf C. R. Heterologous expression of drug-metabolizing enzymes in cellular and whole animal models (Review). Toxicology 1993; 82: 3–20
   PubMed Web of Science ®Google Scholar
• Langenbach R., Smith P. B., Crespi C. Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology (Review). Mutat. Res. 1992; 277: 251–275
   PubMed Web of Science ®Google Scholar
• Townsend A. J., Tu C. P., Cowan K. H. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: Effect on cellular sensitivity to cytotoxic agents. Molec. Pharmacol. 1992; 41: 230–236
   PubMed Web of Science ®Google Scholar
• Morrow C. S., Chiu J., Cowan K. H. Posttranscriptional control of glutathione S-transferase pi gene expression in human breast cancer cells. J. Biol. Chem. 1992; 267: 10544–10550
   PubMed Web of Science ®Google Scholar
• Bunting K. D., Townsend A. J. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. J. Biol. Chem. 1996; 271: 11884–11890
   PubMed Web of Science ®Google Scholar
• Moscow J. A., Fairchild C. R., Madden M. J., Ransom D. T., Wieand H. S., O'Brien E. E., Poplack D. G., Cossman J., Myers C. E., Cowan K. H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989; 49: 1422–1428
   PubMed Web of Science ®Google Scholar
• Rhoads D. M., Zarlengo R. P., Tu C. P. The basic glutathione S-transferases from human livers are products of separate genes. Biochem. Biophys. Res. Commun. 1987; 145: 474–481
   PubMed Web of Science ®Google Scholar
• DeJong J. L., Chang C.-M., Whang-Peng J., Knutsen T., Tu C.-P. D. The human liver glutathione S-transferase gene superfamily: Expression and chromosome mapping of an Hb subunit cDNA. Nucl. Acids Res. 1988; 16: 8541–8554
   PubMed Web of Science ®Google Scholar
• Buetler T. M., Eaton D. L. Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues. Cancer Res. 1992; 52: 314–318
   PubMed Web of Science ®Google Scholar
• Townsend A. J., Goldsmith M. E., Pickett C. B., Cowan K. H. Isolation, characterization, and expression in Escherichia coli of two murine mu class glutathione S-transferase cDNAs homologous to the rat subunits 3 (Yb1) and 4 (Yb2). J. Biol. Chem. 1989; 264: 21582–21590
   PubMed Web of Science ®Google Scholar
• Dogra S., Doehmer J., Glatt H., Molders H., Siegert P., Freidberg T., Seidel A., Oesch F. Stable expression of rat cytochrome P-4501A1 cDNA in V79 chinese hamster cells and their use in mutagenicity testing. Mol. Pharm. 1990; 37: 608–613
   PubMed Web of Science ®Google Scholar
• Doehmer J., Dogra S., Friedberg T., Monier S., Adesnik M., Glatt H., Oesch F. Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B1. Proc. Natl. Acad. Sci. USA 1988; 85: 5769–5773
   PubMed Web of Science ®Google Scholar
• Schneider E., Horton J. K., Yang C. H., Nakagawa M., Cowan K. H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res. 1994; 54: 152–158
   PubMed Web of Science ®Google Scholar
• Fields W. R., Morrow C. S., Townsend A. J. Overexpression of stably transfected human glutathione S-transferase (GST) P1-1 protects against DNA damage by benzo[a]pyrene diol epoxide (BPDE) in human T47D cells. Molec. Pharmacol. 1998; 54: 298–304
   PubMed Web of Science ®Google Scholar
• Townsend A. J., Fields W. R., Haynes R. L., Karper A. J., Li Y., Doehmer J., Morrow C. S. Chemoprotective functions of glutathione S-transferases in cell lines induced to express specific isozymes by stable transfection. Chem. Biol. Interact. 1998; 111–112: 389–407
   PubMed Web of Science ®Google Scholar
• Sims P. The metabolic activation of chemical carcinogens (Review). Br. Med. Bull. 1980; 36: 11–18
   PubMed Web of Science ®Google Scholar
• Shimada T., Martin M. V., Pruess S. D., Marnett L. J., Guengerich F. P. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 1989; 49: 6304–6312
   PubMed Web of Science ®Google Scholar
• Wei S. J., Chang R. L., Hennig E., Cui X. X., Merkler K. A., Wong C. Q., Yagi H., Jerina D. M., Conney A. H. Mutagenic selectivity at the HPRT locus in V-79 cells: Comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,10-epoxide enantiomers with high and low carcinogenic activity. Carcinogenesis 1994; 15: 1729–1736
   PubMed Web of Science ®Google Scholar
• Wei S. J., Chang R. L., Bhachech N., Cui X. X., Merkler K. A., Wong C. Q., Hennig E., Yagi H., Jerina D. M., Conney A. H. Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-di-hydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells. Cancer Res. 1993; 53: 3294–3301
   PubMed Web of Science ®Google Scholar
• Robertson I. G., Guthenberg C., Mannervik B., Jernstrom B. Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Cancer Res. 1986; 46: 2220–2224
   PubMed Web of Science ®Google Scholar
• Vickers P., Dufresne M., Cowen K. Relation between cytochrome P4501A1 expression and estrogen receptor content of human breast cancer cells. Mol. Endocrinol. 1989; 3: 157–164
   PubMed Web of Science ®Google Scholar
• Glatt H., Gemperlein I., Turchi G., Heinritz H., Doehmer J., Oesch F. Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies (Review). Molec. Toxicol. 1987; 1: 313–334
   PubMedGoogle Scholar
• McLean M., Dutton M. F. Cellular interactions and metabolism of aflatoxin: An update. Pharmacol. Ther. 1995; 65: 163–192
   PubMed Web of Science ®Google Scholar
• Eaton D. L., Gallagher E. P. Mechanisms of aflatoxin carcinogenesis (Review). Annu. Rev. Pharmacol. Toxicol. 1994; 34: 135–172
   PubMed Web of Science ®Google Scholar
• Buetler T. M., Slone D., Eaton D. L. Comparison of the aflatoxin B1-8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat. Biochem. Biophys. Res. Commun. 1992; 188: 597–603
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Judah D. J., McLellan L. I., Kerr L. A., Peacock S. D., Neal G. E. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel Alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem. J. 1991; 279: 385–398
   PubMed Web of Science ®Google Scholar
• Johnson W. W., Harris T. M., Guengerich F. P. Kinetics and mechanism of hydrolysis of aflatoxin B1 exo-8,9-epoxide and rearrangement of the dihydrodiol. J. Am. Chem. Soc. 1996; 118: 8213–8220
   Web of Science ®Google Scholar
• Merlos M., Sanchez R. M., Camarasa J., Adzet T. Flavonoids as inhibitors of rat liver cytosolic glutathione S-transferase. Experientia 1991; 47: 616–619
   PubMedGoogle Scholar
• Ahmad H., Singh S. V., Awasthi Y. C. Inhibition of bovine lens glutathione S-transferases by hematin, bilirubin, and bromosulfophthalein. Lens Eye Toxic Res. 1991; 8: 431–440
   PubMedGoogle Scholar
• Datta K., Kulkarni A. P. Inhibition of mammalian hepatic glutathione S-transferases by acetylenic fatty acids. Toxicol. Lett. 1994; 73: 157–165
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Chalmers J. Bile acid inhibition of basic and neutral glutathione S-transferases in rat liver. Biochem. J. 1983; 215: 581–588
   PubMed Web of Science ®Google Scholar
• Bogaards J., Venekamp J. C., Van B. P. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. Chem. Res. Toxicol. 1997; 10: 310–317
   PubMed Web of Science ®Google Scholar
• Listowsky I., Abramovitz M., Homma H., Niitsu Y. Intracellular binding and transport of hormones and xenobiotics by glutathione-S-transferases (Review). Drug Metab. Rev. 1988; 19: 305–318
   PubMed Web of Science ®Google Scholar
• Redegeld F., Hofman G. A., Van de Loo P. G. F., Koster A. S., Noordhoek J. Nephrotoxicity of the glutathione conjugate of menadione (2-methyl-1,4-naphthoquinone) in the isolated perfused rat kidney. Role of metabolism by gamma-glutamyltranspeptidase and probenecid-sensitive transport. J. Pharmacol. Exp. Ther. 1991; 256: 665–669
   PubMed Web of Science ®Google Scholar
• Horvath J. J., Witmer C. M., Witz G. Nephrotoxicity of the 1:1 acrolein–glutathione adduct in the rat. Toxicol. Appl. Pharmacol. 1992; 117: 200–207
   PubMed Web of Science ®Google Scholar
• Ramu K., Perry C. S., Ahmed T., Pakenham G., Kehrer J. P. Studies on the basis for the toxicity of acrolein mercapturates. Toxicol. Appl. Pharmacol. 1996; 140: 487–498
   PubMed Web of Science ®Google Scholar